Ishizawa Miyu, Miyasaka Yuya, Souda Hikaru, Ono Takashi, Chai Hongbo, Sato Hiraku, Iwai Takeo
Department of Heavy Particle Medical Science, Yamagata University Graduate School of Medical Science, Yamagata, Japan.
Department of Radiation Oncology, Yamagata University Faculty of Medicine, Yamagata, Japan.
Int J Part Ther. 2024 Nov 26;15:100637. doi: 10.1016/j.ijpt.2024.100637. eCollection 2025 Mar.
This study aims to determine dosimetric influence of rectal gas in carbon ion radiation therapy (CIRT) for prostate cancer and to establish a procedure for removal rectal gas in clinical scenarios.
We analyzed 18 prostate cancer cases with bulky rectal gas. The dose distribution was recalculated on computed tomography (CT) with bulky rectal gas (gasCT) after creating the initial plan on a CT without bulky rectal gas, and the doses were transformed using a displacement vector field. This created a dose distribution simulation irradiated with the residual rectal gas. Among 12 fractions (fx) for prostate cancer CIRT, different residual rectal gas fx were used to develop 12 dose distributions, each of which was compared with that in the initial plan. Clinical target volume (D, D), rectum, and rectal wall (V, V) parameters were assessed. We investigated the indicators associated with these dose changes using digital reconstruction radiograph (DRR) images.
The dosimetric changes in the clinical target volume were not significantly different from that in the initial treatment plan for both D and D99.5%. Compared to the initial plan, the dose-volume histogram parameters showed changes exceeding 1 cm when residual rectal gas was present in the following number of fractions: 8 fx for V rectum, 5 fx for V rectum, 10 fx for V rectal wall, and 11 fx for V rectal wall. Changes in rectal and rectal wall parameters were highly correlated with the extent of rectal gas assessed on DRR images.
Rectal gas removal may not be necessary up to 4 fx. Moreover, indicators related to dose changes based on DRR images were highly correlated with dose changes, revealing the possibilities of estimating dose changes due to rectal gas from kV-x-ray images and using gas effect evaluation during CIRT irradiation.
本研究旨在确定直肠癌气体在前列腺癌碳离子放射治疗(CIRT)中的剂量学影响,并建立临床场景中去除直肠气体的程序。
我们分析了18例伴有大量直肠气体的前列腺癌病例。在没有大量直肠气体的CT上创建初始计划后,在有大量直肠气体的计算机断层扫描(CT)(气体CT)上重新计算剂量分布,并使用位移矢量场转换剂量。这创建了用残留直肠气体照射的剂量分布模拟。在前列腺癌CIRT的12个分次(fx)中,使用不同的残留直肠气体fx来生成12种剂量分布,每种剂量分布都与初始计划中的剂量分布进行比较。评估临床靶体积(D、D)、直肠和直肠壁(V、V)参数。我们使用数字重建射线照片(DRR)图像研究与这些剂量变化相关的指标。
对于D和D99.5%,临床靶体积的剂量学变化与初始治疗计划中的变化无显著差异。与初始计划相比,当残留直肠气体存在于以下分次数量时,剂量体积直方图参数显示变化超过1 cm:直肠V为8个fx,直肠V为5个fx,直肠壁V为10个fx,直肠壁V为11个fx。直肠和直肠壁参数的变化与DRR图像上评估的直肠气体范围高度相关。
在4个分次以内可能无需去除直肠气体。此外,基于DRR图像的与剂量变化相关的指标与剂量变化高度相关,揭示了从千伏X射线图像估计直肠气体引起的剂量变化以及在CIRT照射期间使用气体效应评估的可能性。